Salarius Pharmaceuticals Historical PE Ratio image   This SLRX PE ratio history page last updated 2/27/2023
Salarius Pharmaceuticals Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/10/2022
1.91-2.47-9.88NA
Q2 2022
8/5/2022
5.00-2.25-9.00NA
Q1 2022
5/12/2022
5.55-3.25-13.00NA
Q4 2021
3/10/2022
12.50-2.25-9.00NA
Q3 2021
11/4/2021
20.88-2.00-8.00NA
Q2 2021
8/5/2021
20.08-1.75-7.00NA
Q1 2021
5/12/2021
28.75-1.50-6.00NA
Q4 2020
3/18/2021
37.50-2.50-10.00NA
Q3 2020
11/11/2020
19.10-2.50-10.00NA
Q2 2020
8/12/2020
26.75-3.25-13.00NA
Q1 2020
5/14/2020
21.00-5.50-22.00NA
Q4 2019
3/23/2020
15.38-11.00-44.00NA
Q3 2019
11/13/2019
100.25-18.25-73.00NA
Q2 2019
7/17/2019
392.00-50.00-200.00NA
Q1 2019
5/1/2019
313.25-3.00-12.00NA
Q4 2018
3/6/2019
202.00-2.75-11.00NA
Q3 2018
11/5/2018
356.25-3.75-15.00NA
Q2 2018
8/1/2018
506.25-12.50-50.00NA
Q1 2018
5/2/2018
2762.50-11.50-46.00NA
Q4 2017
3/7/2018
2918.75-11.50-46.00NA
Q3 2017
11/6/2017
2178.25-13.50-54.00NA
Q2 2017
8/2/2017
2500.00-12.75-51.00NA
Q1 2017
5/3/2017
2043.75-12.25-49.00NA
Q4 2016
3/8/2017
2500.00-12.00-48.00NA
Q3 2016
11/2/2016
3081.25-16.25-65.00NA
Q2 2016
8/3/2016
7187.50-17.75-71.00NA
Q1 2016
5/4/2016
6506.25-15.25-61.00NA
Q4 2015
3/8/2016
4518.75-12.75-51.00NA
Q3 2015
11/4/2015
7193.75-13.25-53.00NA
Q2 2015
8/5/2015
9393.75-11.75-47.00NA
Q1 2015
5/6/2015
11062.50-14.75-59.00NA
FY 2014
3/17/2015
14356.25-45.50-182.00NA
Salarius Pharmaceuticals PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/10/2022
1.91-2.47-10.22NA
Q2 2022
8/5/2022
5.00-2.25-9.75NA
Q1 2022
5/12/2022
5.55-3.25-9.25NA
Q4 2021
3/10/2022
12.50-2.25-7.50NA
Q3 2021
11/4/2021
20.88-2.00-7.75NA
Q2 2021
8/5/2021
20.08-1.75-8.25NA
Q1 2021
5/12/2021
28.75-1.50-9.75NA
Q4 2020
3/18/2021
37.50-2.50-13.75NA
Q3 2020
11/11/2020
19.10-2.50-22.25NA
Q2 2020
8/12/2020
26.75-3.25-38.00NA
Q1 2020
5/14/2020
21.00-5.50-84.75NA
Q4 2019
3/23/2020
15.38-11.00-82.25NA
Q3 2019
11/13/2019
100.25-18.25-74.00NA
Q2 2019
7/17/2019
392.00-50.00-59.50NA
Q1 2019
5/1/2019
313.25-3.00-22.00NA
Q4 2018
3/6/2019
202.00-2.75-30.50NA
Q3 2018
11/5/2018
356.25-3.75-39.25NA
Q2 2018
8/1/2018
506.25-12.50-49.00NA
Q1 2018
5/2/2018
2762.50-11.50-49.25NA
Q4 2017
3/7/2018
2918.75-11.50-50.00NA
Q3 2017
11/6/2017
2178.25-13.50-50.50NA
Q2 2017
8/2/2017
2500.00-12.75-53.25NA
Q1 2017
5/3/2017
2043.75-12.25-58.25NA
Q4 2016
3/8/2017
2500.00-12.00-61.25NA
Q3 2016
11/2/2016
3081.25-16.25-62.00NA
Q2 2016
8/3/2016
7187.50-17.75-59.00NA
Q1 2016
5/4/2016
6506.25-15.25-53.00NA
Q4 2015
3/8/2016
4518.75-12.75-52.50NA
Q3 2015
11/4/2015
7193.75-13.25-85.25NA
Q2 2015
8/5/2015
9393.75-11.75NANA
Q1 2015
5/6/2015
11062.50-14.75NANA
FY 2014
3/17/2015
14356.25-45.50NANA
Quotes delayed 20 minutes

Email EnvelopeFree SLRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Salarius Pharmaceuticals (SLRX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SLS PE Ratio History
SMLR PE Ratio History
SMMT PE Ratio History
SMTI PE Ratio History
SNDA PE Ratio History
SNDX PE Ratio History
SNGX PE Ratio History
SNOA PE Ratio History
SNPX PE Ratio History
SNSE PE Ratio History
How should the SLRX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Salarius Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this SLRX Historical PE Ratio page.

What is the average historical PE for SLRX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The SLRX historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for SLRX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The SLRX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Salarius Pharmaceuticals Historical PE Ratio information for Salarius Pharmaceuticals' stock. The average SLRX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SLRX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SLRX historical PE result, against the recent PE: when this page was posted on 2/24/2023, the most recent closing price for SLRX had been 2.17, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on SLRX or any other given stock, valuation analysis for SLRX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Salarius Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SLRX. Thanks for visiting, and the next time you need to research SLRX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Union Pacific shares outstanding history, YOSH YTD Return, Top Ten Hedge Funds Holding DVOL.

 

Salarius Pharmaceuticals Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.